Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IOngoingDec 27, 2023THE ROCKMarketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with Sildenafil an ingredient found in an FDA approved product for the treatment of...Noah's Wholesale LLC · D-0158-2024Class IIOngoingDec 27, 2023NYSTATIN 150 MULabeling: Label Error on Declared Strength: Assay value on the label is incorrect.Fagron, Inc · D-0157-2024Class IIOngoingDec 27, 2023NYSTATIN 2 BULabeling: Label Error on Declared Strength: Assay value on the label is incorrect.Fagron, Inc · D-0156-2024Class IIOngoingDec 27, 2023NYSTATIN 500 MULabeling: Label Error on Declared Strength: Assay value on the label is incorrect.Fagron, Inc · D-0155-2024Class IIOngoingDec 27, 2023NYSTATIN 5BULabeling: Label Error on Declared Strength: Assay value on the label is incorrect.Fagron, Inc · D-0154-2024Class ITerminatedDec 27, 2023Phenytoin Oral SuspensionFailed Content Uniformity SpecificationsThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · D-0153-2024Class IIOngoingDec 27, 2023Selenium Sulfide 2.25% ShampooCGMP Deviations: Stability data does not support expiry date.Private Label Partners, Inc. · D-0152-2024Class ICompletedDec 27, 2023TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray PowderChemical Contamination; presence of benzene.Insight Pharmaceuticals Corporation · D-0151-2024Class IITerminatedDec 20, 2023Liothyronine Sodium TabletsFailed Impurities/Degradation SpecificationsSun Pharmaceutical Industries Inc · D-0150-2024Class IIICompletedDec 20, 2023VotrientFailed Dissolution SpecificationsSiegfried Barbera, SL · D-0149-2024Class IITerminatedDec 20, 2023Penicillamine Tablets USP 250 mgFailed Dissolution SpecificationsLupin Pharmaceuticals Inc. · D-0148-2024Class IICompletedDec 13, 2023ROPivacaine HCl 0.2% PF in Sodium Chloride 1STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was...STAQ Pharma, Inc. · D-0147-2024Class IICompletedDec 13, 2023Ondansetron InjectionFailed pH SpecificationsBaxter Healthcare Corporation · D-0146-2024Class IOngoingDec 13, 2023SANDIMMUNE Oral SolutionCrystallization: bottles of Sandimmune Oral Solution were determined to contain crystalsNovartis Pharmaceuticals Corporation · D-0144-2024Class IIOngoingDec 13, 2023KinderMed INFANTS' PAIN & FEVER AcetaminophenFailed Impurities/Degradation SpecificationsKinder Farms LLC · D-0143-2024Class IIOngoingDec 13, 2023KinderMed KIDS' PAIN & FEVER AcetaminophenFailed Impurities/Degradation SpecificationsKinder Farms LLC · D-0142-2024Class IICompletedDec 13, 2023ceFAZolin sodium in Sterile Water for injectionLack of assurance of sterility.Wells Pharma of Houston LLC · D-0141-2024Class IIITerminatedDec 13, 2023LET GelProduct Mix-up: Incorrect Product FormulationRight Value Drug Stores, LLC dba Carie Boyd's Prescription Shop · D-0140-2024Class IIOngoingDec 13, 2023Trospium Chloride Extended-Release CapsulesFailed Tablets/Capsules specifications; missing/broken/extra tablets within the capsulesPadagis US LLC · D-0139-2024Class IOngoingDec 13, 2023Dr. Ergin's SugarMDMARKETED WITHOUT AN APPROVED NDA/ANDA: Product found to be tainted with metformin and glyburideSugarmds LLC · D-0138-2024Class IIITerminatedDec 13, 2023buPROPion Hydrochloride Extended-Release TabletsFailed Dissolution SpecificationsSun Pharmaceutical Industries Inc · D-0137-2024Class IOngoingDec 6, 2023Kuka Flex Forte capletsMarketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.Botanical Be · D-0226-2024Class IOngoingDec 6, 2023Reumo Flex capletsMarketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.Botanical Be · D-0225-2024Class IOngoingDec 6, 2023Artri King Reforzado con Origa y Omega 3 tabletsMarketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.Botanical Be · D-0224-2024Class ITerminatedDec 6, 2023VITRAKVIMicrobial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testingBayer Healthcare Pharmaceuticals Inc. · D-0145-2024Class IITerminatedDec 6, 2023PAROXETINE tabletsFailed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of...Golden State Medical Supply Inc. · D-0130-2024Class IITerminatedDec 6, 2023PAROXETINE tabletsFailed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of...Golden State Medical Supply Inc. · D-0129-2024Class IITerminatedDec 6, 2023PAROXETINE tabletsFailed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of...Golden State Medical Supply Inc. · D-0128-2024Class IIITerminatedDec 6, 2023Testosterone GelOOS for viscosityTeva Pharmaceuticals USA, Inc · D-0127-2024Class IIITerminatedDec 6, 2023Aminocaproic Acid Oral SolutionFailed Excipient Specifications: high content of ethylene glycol (EG)VistaPharm LLC · D-0126-2024Class IIIOngoingDec 6, 2023Tropicamide 1%Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL single-use syringe instead of a 5 mL dropperFagron Compounding Services · D-0125-2024Class IIOngoingDec 6, 2023Naproxen TabletsLabeling: Label Mix-Up-Indomethacin bottles may be labeled as NaproxenGlenmark Pharmaceuticals Inc., USA · D-0124-2024Class IIOngoingDec 6, 2023Indomethacin 25mg CapsulesLabeling: Label Mix-Up-Indomethacin bottles may be labeled as NaproxenGlenmark Pharmaceuticals Inc., USA · D-0123-2024Class IIOngoingDec 6, 2023Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of ParoxetineApotex Corp. · D-0122-2024Class IIOngoingDec 6, 2023Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of ParoxetineApotex Corp. · D-0121-2024Class IIOngoingDec 6, 2023Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of ParoxetineApotex Corp. · D-0120-2024Class IIOngoingDec 6, 2023Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of ParoxetineApotex Corp. · D-0119-2024Class IOngoingNov 29, 2023LEADER brand Lubricant Eye DropsNon-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.Cardinal Health Inc. · D-0136-2024Class IOngoingNov 29, 2023LEADER brand Dry Eye ReliefNon-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.Cardinal Health Inc. · D-0135-2024Class IOngoingNov 29, 2023LEADER brand Lubricant Eye DropsNon-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.Cardinal Health Inc. · D-0134-2024